The global genomics market is anticipated to grow at a considerable CAGR of 15.3% during the forecast period. The key factors that are contributing to the market growth are key players operating in the market are adopting various strategies such as acquisition, mergers, new product launches, and other are such factors that assist in market growth. For instance,
Browse the full report description of “Genomics Market Size, Share & Trends Analysis Report by Deliverable (Product, and Services), by Technology (Sequencing, PCR, Nucleic Acid Extraction and Purification, Microarray, and Other) by Application (Drug Discovery and Development, Diagnostics, Agriculture and Animal Research, and Other), and by End-User (Hospitals & Clinics, Academic and Research Centers, Pharmaceutical & Biotechnology Companies, and Other), Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/genomics-market
• In February 2022, Intellia Therapeutics, Inc., has acquired Rewrite Therapeutics, Inc., for the further expansion of Intellia's industry-leading genome editing toolbox with the addition of CRISPR/Cas9 and base editing technologies to make precisely targeted changes to DNA for new possibilities and the potential to target diseases.
• In April 2021, the Biden administration has invested $1.7 billion to improve the detection, monitoring, and mitigation of SARS-CoV-2 variants and also for building infrastructure for future genomic sequencing. This funding is made to expand the capacity for genomic sequencing, with additional future funding to follow that will reach $1 billion.
• In December 2020, AstraZeneca has acquired Alexion Pharmaceuticals, Inc., to build combined expertise in immunology and precision medicines to accelerate innovation and deliver enhanced value for shareholders, patients, and the rare disease communities.
• In June 2020, Merck and 10x Genomics, Inc., developed a new option for biological experiments with barcode technology to screen single cells using CRISPR libraries. Under this collaboration, companies are innovating two new technologies such as single cell transcriptomics and pooled CRISPR screening under the 10x Compatible Partnership Program.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Deliverable
o By Technology
o By Application
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Agilent Technologies, Inc., Danaher Corp., Eurofins Scientific Ltd., F. Hoffmann-La Roche Ltd., Illumina Inc., Quest Diagnostics, Thermo Fisher Scientific, and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Genomics Market Report Segment
By Deliverable
By Technology
By Application
By End-User
Global Genomics Market Report by Region
North America
• US
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/genomics-market